| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
68,446 |
47,041 |
$9.38M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
100,278 |
64,024 |
$8.15M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
66,812 |
41,882 |
$8.00M |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
93,892 |
52,629 |
$4.15M |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
149,907 |
82,455 |
$4.04M |
| 90832 |
Psychotherapy, 30 minutes with patient |
71,049 |
55,869 |
$3.77M |
| T1003 |
Lpn/lvn services, up to 15 minutes |
126,733 |
69,525 |
$2.91M |
| H0048 |
Alcohol and/or other drug testing: collection and handling only, specimens other than blood |
169,118 |
93,540 |
$2.33M |
| H0006 |
Alcohol and/or drug services; case management |
28,987 |
20,680 |
$962K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
8,645 |
6,192 |
$666K |
| 99215 |
Prolong outpt/office vis |
1,872 |
1,251 |
$305K |
| 90791 |
Psychiatric diagnostic evaluation |
2,259 |
2,143 |
$234K |
| H0015 |
Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education |
1,722 |
333 |
$201K |
| H0038 |
Self-help/peer services, per 15 minutes |
8,389 |
5,615 |
$193K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,881 |
3,559 |
$188K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
942 |
890 |
$169K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
1,325 |
1,241 |
$148K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
660 |
626 |
$74K |
| H0001 |
Alcohol and/or drug assessment |
453 |
450 |
$35K |
| 99205 |
Prolong outpt/office vis |
99 |
96 |
$20K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
150 |
148 |
$12K |
| H0005 |
Alcohol and/or drug services; group counseling by a clinician |
407 |
196 |
$9K |
| 90834 |
Psychotherapy, 45 minutes with patient |
110 |
97 |
$8K |
| 80346 |
|
523 |
518 |
$5K |
| 80364 |
|
528 |
526 |
$5K |
| G2087 |
Office-based treatment for opioid use disorder, including care coordination, individual therapy and group therapy and counseling; at least 60 minutes in a subsequent calendar month |
96 |
83 |
$5K |
| 80361 |
|
516 |
514 |
$5K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
24 |
24 |
$3K |
| 80354 |
|
523 |
520 |
$3K |
| 80324 |
|
523 |
518 |
$3K |
| 80353 |
|
521 |
518 |
$3K |
| 80365 |
|
514 |
512 |
$3K |
| 80366 |
|
516 |
511 |
$2K |
| 80358 |
|
512 |
506 |
$2K |
| 80355 |
|
525 |
520 |
$2K |
| 80356 |
|
522 |
519 |
$2K |
| 80349 |
|
515 |
515 |
$2K |
| 80348 |
|
525 |
520 |
$2K |
| 90837 |
Psychotherapy, 53 minutes with patient |
20 |
16 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
57 |
45 |
$1K |
| 80352 |
|
64 |
64 |
$288.61 |
| 80359 |
|
65 |
64 |
$244.03 |
| 80369 |
|
12 |
12 |
$42.44 |